<DOC>
	<DOCNO>NCT01273506</DOCNO>
	<brief_summary>The purpose study evaluate bioequivalence 50-mg tapentadol ( CG5503 ) dose administer two 25-mg ER , TRF tablets relative one 50-mg ER TRF tablet healthy Japanese male participant .</brief_summary>
	<brief_title>A Study Compare Bioequivalence 50-mg Tapentadol ( CG5503 ) Dose Administered Two 25-mg Tablets Relative One 50-mg Tablet</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , single-center , randomize ( study drug assign chance ) , 2-way crossover study ( participant may receive different intervention sequentially trial ) . All participant receive single 50-mg dose tapentadol ( CG5503 ) 2 period , randomize order , two 25-mg TRF tablets one 50-mg TRF tablet . All participant randomly assign 1 2 possible treatment sequence receive follow treatment , 1 period : Treatment A : two tapentadol ( CG5503 ) ER 25-mg TRF tablet , administer single oral dose fast condition Treatment B : one tapentadol ( CG5503 ) ER 50-mg TRF tablet , administer single oral dose fast condition Each period separate 7 - 14 day</detailed_description>
	<criteria>Japanese participant reside outside Japan 5 year whose parent maternal paternal grandparent Japanese , determine participant 's verbal report Deemed healthy basis prestudy physical examination , medical history ( include smoke habit ) , 12lead electrocardiogram ( ECG ) , vital sign , clinical laboratory parameter ( serum chemistry , serology hematology ) perform within 21 day study drug administration Must impregnate partner . Body mass index ( BMI ) ( weight [ kg ] /height [ m2 ] ) 18.5 25 kg/m2 , inclusive , body weight less 50 kg Blood pressure ( participant supine 5 minute ) 100 140 mm Hg systolic , inclusive , 50 90 mm Hg diastolic , inclusive History seizure disorder epilepsy ¿mild moderate traumatic brain injury , stroke , transient ischemic attack , brain neoplasm within 1 year screen history ¿severe traumatic brain injury ( consist 1 following : brain contusion intracranial hematoma episode ( ) 24 hour duration unconsciousness posttraumatic amnesia ) within 15 year screen , history ¿severe traumatic brain injury result ongoing sequela suggest transient change consciousness symptom suggestive thereof History gastrointestinal disease affect absorption , gastric surgery history current significant medical illness History clinically significant allergy , especially know hypersensitivity/intolerance contraindication opioids , opioid antagonist ( e.g. , naloxone ) , benzodiazepine ( e.g. , diazepam , clonazepam , lorazepam ) , study drug formulation component , excipients formulation , heparin ( use heparin lock necessary ) History , reason believe participant history lifetime opioid abuse , drug alcohol abuse within past 5 year</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>tapentadol</keyword>
	<keyword>NUCYNTA</keyword>
	<keyword>CG5503</keyword>
	<keyword>R331333</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy volunteer</keyword>
</DOC>